Cyclic peptide CXCR4 antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reissue Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reissue Patent

active

RE042274

ABSTRACT:
Provided are lactam-cyclized peptide CXCR4 antagonists useful in the treatment of cancers, rheumatoid arthritis, pulmonary fibrosis, and HIV infection.

REFERENCES:
patent: 2004 196769 (2004-07-01), None
patent: WO 2007/096662 (2007-08-01), None
Tamamura et al. (“Development of Anti-HIV Agents Targeting Dynamic Supramolecular Mechanism: Entry and Fusion Inhibitors Based on CXCR4/CCR5 Antagonists and gp41-C34-Remodeling Peptides,” Current HIV Research, 2005, 3, 289-301).
Grande, et al., “Small Molecules Anti-HIV Therapeutics Targeting CXCR4,”Curr. Pharm. Design14:385-404 (2008).
Tamamura et al., “Development of Low Molecular Weight CXCR4 Antagonists by Exploratory Structural Tuning of Cyclic Tetra- and Pentapeptide-Scaffolds Towards the Treatment of HIV Infection, Cancer Metastasis and Rheumatoid Arthritis,”Curr. Med. Chem.14:93-102 (2007).
Tamamura, et al., “Development of Anti-HIV Agents Targeting Dynamic Supramolecular Mechanism: Entry and Fusion Inhibitors Based on CXCR4/CCR5 Antagonists and gp41-C34-Remodeling Peptides,”Curr. HIV Research3:289-301 (2005).
Ueda, et al., “Structure-Activity Relationships of Cyclic Peptide-Based Chemokine Receptor CXCR4 Antagonists: Disclosing the Importance of Side-Chain and Backbone Functionalities,”J. Med. Chem.50:192-198 (2007).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cyclic peptide CXCR4 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic peptide CXCR4 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic peptide CXCR4 antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2678625

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.